Assessment of dd-cfDNA Levels in Clinically Stable Lung Allograft Recipients Beyond the Initial 2 y Posttransplant

Donor-derived cell-free DNA (dd-cfDNA) is a useful biomarker for the diagnosis of acute allograft injury within the first 1 to 2 y after lung transplant, but its utility for diagnosing chronic lung allograft dysfunction (CLAD) has not yet been studied. Understanding baseline dd-cfDNA kinetics beyond...

Descripción completa

Detalles Bibliográficos
Autores principales: Trindade, Anil J., Chapin, Kaitlyn C., Mullican, Amy, Gray, Jennifer N., Hoy, Haley, Demarest, Caitlin T., Lambright, Eric S., McPherson, Katie A., Norfolk, Stephanie G., Robbins, Ivan M., Bacchetta, Matthew, Erasmus, David B., Shaver, Ciara M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Lung Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671749/
https://www.ncbi.nlm.nih.gov/pubmed/36406896
http://dx.doi.org/10.1097/TXD.0000000000001411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671749/
https://www.ncbi.nlm.nih.gov/pubmed/36406896
http://dx.doi.org/10.1097/TXD.0000000000001411

Ejemplares similares